Jeffrey I.D. Lewis Esq.

Norton Rose Fulbright US LLP

Jeffrey I. D. Lewis is a partner at Norton Rose Fulbright, resident in the firm's New York office.  A chemical engineer and registered patent attorney, Jeff concentrates on patent and trademark litigation, counseling, and licensing, as well as other intellectual property and general litigation.  He regularly represents plaintiffs as well as defendants ─ both at trial and on appeal ─ in a range of technology-related sectors with a focus on pharmaceuticals, chemicals, mechanical/medical-device, biotechnology and life sciences, and has represented pharmaceutical innovators in numerous Abbreviated New Drug Application (ANDA) patent litigations.  Jeff has been lead counsel in several dozen cases before the U.S. federal district courts and other tribunals, often trying them to conclusion, and argued numerous appeals before the U.S. Court of Appeals for the Federal Circuit.

He is a past President of the American Intellectual Property Law Association (AIPLA) and the United States national group of the Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI), as well as a fellow of both AIPLA and the American Bar Foundation.  Jeff is active in a number of other intellectual property bar associations.  In addition to his work on behalf of clients, Jeff has appeared as Counsel of Record for amicus curiae in numerous cases before the Supreme Court of the United States, U.S. Court of Appeals for the Federal Circuit, and other courts involving a diverse array of issues.

He is an editor-in-chief of the AIPLA/Bloomberg Law treatise Privilege and Professional Confidences: An International Review.